
北美角膜移植市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析 [穿透性角膜移植术、后弹力层膜内皮角膜移植术 (DMEK)、后弹力层剥离内皮角膜移植术 (DSEK)、角膜缘干细胞移植等]、适应症 (真菌性角膜溃疡、福克斯营养不良、圆锥角膜、角膜炎等)和最终用户(医院、眼科诊所和门诊手术中心)
No. of Pages: 105 | Report Code: TIPRE00029096 | Category: Life Sciences
No. of Pages: 105 | Report Code: TIPRE00029096 | Category: Life Sciences
角膜失明包括多种疾病传染性和炎症性眼病会导致角膜疤痕,从而导致功能性失明。沙眼、角膜溃疡、新生儿眼炎、干眼症、病毒感染、盘尾丝虫病、麻风病、传统眼药和眼外伤会导致角膜失明。尽管流行病学复杂,但通过及时治疗上述疾病是可以预防角膜失明的。然而,如果由于医疗条件有限而在初期得不到治疗,角膜移植是治疗角膜受损患者的唯一选择。根据美国角膜研究基金会 2020 年的统计数据,每 10 万人中约有 50-200 人患有圆锥角膜疾病。因此,包括圆锥角膜疾病在内的眼部疾病发病率不断上升,推动了北美角膜移植市场的增长。
随着新的功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动北美角膜移植市场在预测期内实现良好的复合年增长率。
<北美角膜移植市场根据类型、适应症、最终用户和国家进行细分。根据类型,北美角膜移植市场分为穿透性角膜移植术、后弹力膜内皮角膜移植术(DMEK)、后力层剥离内皮角膜移植术(DSEK)、角膜缘干细胞移植等。穿透性角膜移植术领域在 2020 年北美角膜移植市场中占据主导地位,而后弹力层内皮角膜移植术 (DMEK) 领域预计将在预测期内增长最快。根据适应症,北美角膜移植市场分为真菌性角膜溃疡、福克斯营养不良、圆锥角膜、角膜炎等。福克斯营养不良细分市场在 2020 年主导北美角膜移植市场,预计同一细分市场在预测期内增长最快。根据最终用户,北美角膜移植市场分为医院、眼科诊所和门诊手术中心。医院细分市场在 2020 年主导北美角膜移植市场,门诊手术中心细分市场预计在预测期内增长最快。按国家/地区划分,北美角膜移植市场分为美国、加拿大和墨西哥。爱尔康公司;奥罗实验室;角膜生物科学公司;角膜生成;角膜视力;佛罗里达狮子眼库;凯瑞梅德有限公司;生命线科学公司;和 Massachusetts Eye and Ear 是北美角膜移植市场的领先公司。
Strategic insights for North America Corneal Transplantation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 207.03 Million |
Market Size by 2028 | US$ 318.25 Million |
Global CAGR (2021 - 2028) | 6.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Corneal Transplantation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Corneal Transplantation Market is valued at US$ 207.03 Million in 2021, it is projected to reach US$ 318.25 Million by 2028.
As per our report North America Corneal Transplantation Market, the market size is valued at US$ 207.03 Million in 2021, projecting it to reach US$ 318.25 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The North America Corneal Transplantation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Corneal Transplantation Market report:
The North America Corneal Transplantation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Corneal Transplantation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Corneal Transplantation Market value chain can benefit from the information contained in a comprehensive market report.